Melanie Marshall
Direttore Tecnico/Scientifico/R&S presso OSSDSIGN AB
Profilo
Melanie Marshall is currently working as the Vice President-Clinical & Medical Affairs at OssDsign AB since 2022.
Prior to this, she worked as the Vice President-Clinical Operations at ApaTech Ltd.
Ms. Marshall completed her undergraduate degree from Wheaton College (Massachusetts).
Posizioni attive di Melanie Marshall
| Società | Posizione | Inizio |
|---|---|---|
| OSSDSIGN AB | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
Precedenti posizioni note di Melanie Marshall
| Società | Posizione | Fine |
|---|---|---|
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Melanie Marshall
| Wheaton College (Massachusetts) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OSSDSIGN AB | Health Technology |
| Aziende private | 1 |
|---|---|
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Health Technology |
- Borsa valori
- Insiders
- Melanie Marshall
